cmi_logo.png
[Latest] Global Non-Small-Cell Lung Cancer Drug Market Size/Share Worth USD 68,888.6 Million by 2033 at a 8.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 21, 2024 03:30 ET | Custom Market Insights
Austin, TX, USA, May 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Non-Small-Cell Lung Cancer Drug Market Size, Trends and Insights By Cancer Type...
cmi_logo.png
[Latest] Global Colorectal Cancer Market Size/Share Worth USD 30,095.9 Million by 2033 at a 3.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 20, 2024 12:30 ET | Custom Market Insights
Austin, TX, USA, May 20, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Colorectal Cancer Market Size, Trends and Insights By Type of Treatment (Surgery,...
AIMLogo.jpg
AIM ImmunoTech to Participate in Two Upcoming Investor Conferences
May 20, 2024 09:15 ET | AIM ImmunoTech Inc.
OCALA, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that AIM Chief Executive Officer Thomas K. Equels will participate in...
Polycystic Ovary Syndrome (PCOS) Treatment Market
Polycystic Ovary Syndrome (PCOS) Treatment Global Strategic Research Report 2024-2030: North America and Europe Dominates, Asia-Pacific to Exhibit Fastest Growth
May 17, 2024 09:25 ET | Research and Markets
Dublin, May 17, 2024 (GLOBE NEWSWIRE) -- The "Polycystic Ovary Syndrome (PCOS) Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global...
AIMLogo.jpg
AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 16, 2024 07:30 ET | AIM ImmunoTech Inc.
Continued execution across Ampligen® clinical development programs and growing body of positive data in multiple high-value indications Company to host conference call and webcast today, May...
Saladax Biomedical, Inc. 5-FU Fact Sheet
Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test
May 14, 2024 10:00 ET | Saladax Biomedical, Inc.
Bethlehem, PA, May 14, 2024 (GLOBE NEWSWIRE) -- Saladax Biomedical, Inc. (Saladax) is pleased to announce that Health Canada has approved Saladax’s 5-Fluorouracil (My5-FU) Assay for sale in Canada...
ProStarLogo4Color5.11.2021_light blue Tag.png
ProStar Holdings Announces Corporate Update
May 14, 2024 09:00 ET | ProStar
Corporate update
On Tap with KBCO Poster
Breckenridge Brewery Announces On Tap with KBCO Concert Series Featuring Cannons, The Moss and Dehd
May 14, 2024 07:00 ET | Tilray Brands, Inc.
BRECKENRIDGE BREWERY ANNOUNCES ON TAP WITH KBCO CONCERT SERIES FEATURING CANNONS, THE MOSS AND DEHD
LOGO-01.png
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
May 14, 2024 02:02 ET | Burning Rock Biotech Limited
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
Turnstone Logo.jpg
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
May 13, 2024 17:01 ET | Turnstone Biologics Corp.
Turnstone Biologics Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights